FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to ophthalmology and can be used for treatment of open-angle glaucoma of I-II stages. For this purpose neuroprotectors are includes into standard complex of pharmacotherapy. As neuroprotectors used are 2-ethyl-6-methyl-3-hydroxypyridine succinate in dose 300 mg/day and picamilon in dose 150 mg/day.
EFFECT: method ensures expressed reduction of intraocular pressure up to its normalisation.
3 cl, 1 ex, 1 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF GLAUCOMATOUS OPTIC NEUROPATHY | 2015 |
|
RU2578953C1 |
METHOD OF IMPROVEMENT OF VISUAL FUNCTIONS AT PRIMARY OPEN ANGLE GLAUCOMA WITH NORMALISED INTRAOCULAR TENSION | 2007 |
|
RU2351299C1 |
METHOD FOR MACULAR AREA MORPHOMETRIC CHANGES TREATMENT IN CASE OF POLYMORBIDE SOMATIC CONDITIONS | 2016 |
|
RU2622759C1 |
METHOD OF TREATING PRIMARY GLAUCOMA IN PATIENTS WITH ACCOMPANYING ARTERIAL HYPERTENSION | 2015 |
|
RU2607291C1 |
METHOD OF TREATING ELDERLY AND SENILE GLAUCOMA OPTIC NEUROPATHY | 2009 |
|
RU2411033C1 |
METHOD FOR DIAGNOSING THE NEED TO PRESCRIBE GLUCOCORTICOIDS SYSTEMICALLY IN PATIENTS WITH RHEUMATIC DISEASE | 2021 |
|
RU2760260C1 |
METHOD OF TREATMENT GLAUCOMATOUS OPTIC NEUROPATHY | 2015 |
|
RU2577763C1 |
METHOD FOR IMPROVING VISION FUNCTION IN THE CASES OF PRIMARY OPEN ANGLE GLAUCOMA WITH NORMALIZED OPHTHALMIC TONUS | 2003 |
|
RU2259203C2 |
METHOD FOR TREATING THE CASES OF OPEN ANGLE GLAUCOMA | 1997 |
|
RU2145826C1 |
METHOD FOR ASSESSING THE EFFICACY OF NEURORETINOPROTECTION OF PRIMARY OPEN-ANGLE GLAUCOMA ON BASIS OF DETERMINING RATIO OF NEURAL MARKERS | 2018 |
|
RU2681654C1 |
Authors
Dates
2013-10-10—Published
2011-12-23—Filed